接受治疗的发作发生的主要部位为四肢68次，面部48次，胃肠道272次，泌尿生殖系统9次，喉50次。
The primary location of the treated attacks was the extremities in 68 patients, facial in 48, gastrointestinal in 272, genitourinary in 9, and laryngeal in 50.
选择性的CB1受体阻滞剂通过作用该受体，具有治疗肥胖、酒精依赖、尼古丁成瘾、认知障碍以及胃肠道系统疾病等作用。
Selective CB1-R antagonists have potential in the treatment of a number of diseases, such as obesity, alcohol dependence, nicotine addiction, cognitive disorders, and gastrointestinal disorders.
选择性的CB1受体阻滞剂通过作用该受体，具有治疗肥胖、酒精依赖、尼古丁成瘾、认知障碍以及胃肠道系统疾病等作用。
Selective CB1-R antagonists have potential in the treatment of a number of diseases, such as obesity, alcohol dependence, nicotine addiction, cognitive disorders, and gastrointestinal disorders.
应用推荐